Gut Feeling: A Daily Fibre Dose Takes the Edge Off Knee Pain

A daily fibre supplement reduced knee osteoarthritis pain in a small randomized trial, offering an encouraging lead for testing whether feeding gut bacteria can help treat joint pain. ^[2]

The six-week University of Nottingham study found that inulin produced a 1.11-point greater reduction in pain than placebo on a scale running from zero to 10. Its 95% confidence interval ranged from 0.04 to 2.18 points greater reduction, spanning an almost negligible benefit to a considerably larger one. ^[2]

The INSPIRE trial included 117 adults with knee osteoarthritis who completed the study. Participants received inulin, physiotherapy-supported exercise delivered digitally, both interventions, or a placebo. Exercise also reduced pain, and combining the two treatments produced no evidence of an extra benefit beyond their separate effects. ^[2]

The finding gives researchers a human trial result to pursue in a condition marked by persistent pain. Professor Lucy Donaldson of Arthritis UK said six in 10 respondents to a recent lived-experience survey reported arthritis pain most or all of the time. She described the research as preliminary and said diet and physiotherapy could work in different ways. ^[3]

Led by Afroditi Kouraki and colleagues, the study was published in the peer-reviewed journal Nutrients on February 24, 2026. Its results have received renewed attention through a university-supplied ScienceDaily item dated October 27. ^[1][2]

What improved, and by how much

Participants assigned to the supplement took 20 grams of inulin daily. The placebo was 10 grams of maltodextrin. Random assignment gives the comparison more weight than an observation that people who eat more fibre also happen to have less pain. ^[2]

The pain result just cleared the conventional threshold for statistical significance, with a p-value of 0.045. That figure measures how compatible the result is with a model assuming no treatment effect. It does not measure how much relief a patient would notice.

The 1.11-point estimate and its wide confidence interval are more useful guides to the possible size of the benefit. ^[2]

For comparison, physiotherapy-supported exercise produced a 1.55-point greater pain reduction than placebo, with a 95% confidence interval from 0.58 to 2.52 points. Those estimates do not establish that exercise was superior to inulin, but exercise clearly remained an active treatment in this trial. ^[2]

The two approaches also showed different patterns across the physical tests. Inulin improved grip strength compared with placebo, with a p-value of 0.002. Physiotherapy improved performance in a timed test of getting up and moving, and in the number of times participants could stand from a chair in 30 seconds. ^[2]

Those are different kinds of strength and function. A firmer hand grip is an interesting result in a knee arthritis trial, especially when the proposed treatment starts in the gut. It should not be read as a direct measurement of stronger muscles around the affected knee. ^[2]

Inulin also improved measures of sensitivity to painful stimuli. These included pressure pain thresholds, which assess how much pressure becomes painful, and temporal summation, which measures how pain builds with repeated stimulation. The researchers were therefore detecting changes beyond participants' ratings of their knee pain. ^[2]

The inulin group had a dropout rate of 3.6%, compared with 21% in the physiotherapy-supported exercise group. That is useful information about participation over six weeks, although it does not by itself establish why people stayed or left. ^[2][3]

How the gut might reach the joint

Inulin is a prebiotic fibre found in foods including chicory root and Jerusalem artichokes. Unlike a probiotic, which supplies microorganisms, a prebiotic feeds bacteria already living in the gut. Inulin reaches the large intestine, where those bacteria can use it as food. ^[1][3]

As bacteria process fibre, they can produce compounds called short-chain fatty acids, including butyrate. The researchers measured these compounds in participants' blood, alongside GLP-1, a gut hormone involved in appetite and blood-sugar regulation. ^[2][3]

According to the university, butyrate and GLP-1 levels rose among participants taking inulin. Higher GLP-1 levels were also associated with better grip strength. That supplies a possible biological route connecting a dietary supplement to effects elsewhere in the body. ^[3]

The attraction is straightforward: feeding bacteria in the large intestine might change the chemical signals reaching systems involved in pain and muscle function. The combination of altered blood measurements, pain sensitivity and grip strength makes that hypothesis worth testing. ^[2][3]

It also changes the research question. Researchers can now ask whether particular bacterial products or hormonal changes help explain the response, rather than stopping at whether participants reported feeling better.

A useful lead, with a short runway of evidence

The trial lasted only six weeks and was modest in size. It does not establish lasting relief, repair of joint damage or a reason to replace exercise and established care.

Its GLP-1 analysis was exploratory and was not specified in the original protocol. The association with grip strength therefore generates a hypothesis, rather than proving that GLP-1 caused the improvement. ^[2]

There is no sound basis here for putting a universal price on treatment, either. The daily dose was specified, but its typical cost in different places and its tolerability in routine use still need to be established. ^[1][2]

The next step is a larger, longer trial that can test whether the pain benefit repeats, whether it lasts and which patients benefit. The authors also call for work to clarify the mechanism. Measuring gut-related changes according to a plan set before the results arrive would give the proposed explanation a much firmer test. ^[2]

For patients, the next useful result will be whether a modest change on a pain scale translates into easier daily activity over months. Six weeks has supplied a reason to run that test. ^[2]